MSM is sulfur your body can grab fast. Sulfur cross-links collagen, builds keratin in hair and nails, and feeds glutathione, your main antioxidant. MSM does two modest things: it quiets inflammatory signalling and nudges C-reactive protein down 1, and it tops up glutathione so oxidative-stress markers fall under exercise strain 2. It doesn't regrow cartilage or fix a torn meniscus; it eases the load on the joint.
Real but modest, mostly for knees. Five placebo-controlled knee-osteoarthritis trials point the same way: pain down, function up, at roughly the size of a low-dose anti-inflammatory, by eight to twelve weeks. In the anchor trial, 3 g twice daily for twelve weeks dropped pain about a quarter and improved function about a third, side effects the same as placebo 3; replicated since 4 5. Outside knees the data thins: runners on 3 g a day had less post-race muscle pain 2, and skin trials are small combination products 6. "MSM helps knee pain a bit" is what the evidence backs, and where sellers overshoot 7.
Run it as a twelve-week experiment, not a purchase.
A quiet payoff. Weeks one through four, nothing. Around week six the flinch on the first step is gone. By week eight to twelve the stair complaint is something you sometimes forget about, and the hard-training week that needed an extra rest day clears a day faster 3 2. Nobody else notices; this is your own knees. Either the stairs got easier and you keep going at twenty dollars a year, or they didn't and you stop, with a real answer.
MSM isn't the load-bearing fix. Strengthening exercise, weight loss, and NSAIDs for flares top the knee-OA guidance 8. Among supplements, glucosamine plus chondroitin has similar evidence and stacks with MSM 4. Skip the exercise and you're optimising the smaller lever.
The fine print — when to skip it, and what people get wrong
The marketing oversells. No human trial shows MSM rebuilds cartilage; it eases symptoms 7. You're not sulfur-deficient if you eat protein and vegetables. MSM is not DMSO: same sulfur, different molecule, no solvent action.
Skip or ask first: pregnant or breastfeeding (no trial data). On warfarin, mention it to your prescriber before starting. A "sulfa" drug allergy is not a contraindication; sulfonamide antibiotics are a different molecule 1.
Why "nothing happened": quit before week eight, under-dosed at the 500 mg a combination bottle puts per serving, or wrong problem. MSM does nothing for a torn meniscus or bone-on-bone OA; if surgery is on the table, no supplement bridges it.
- 1Butawan M, Benjamin RL, Bloomer RJ (2017). Methylsulfonylmethane: applications and safety of a novel dietary supplement. Nutrients. link
- 2Withee ED, Tippens KM, Dehen R, Tibbitts D, Hanes D, Zwickey H (2017). Effects of methylsulfonylmethane (MSM) on exercise-induced oxidative stress, muscle damage, and pain following a half-marathon: a double-blind, randomized, placebo-controlled trial. Journal of the International Society of Sports Nutrition. link
- 3Kim LS, Axelrod LJ, Howard P, Buratovich N, Waters RF (2006). Efficacy of methylsulfonylmethane (MSM) in osteoarthritis pain of the knee: a pilot clinical trial. Osteoarthritis and Cartilage. link
- 4Usha PR, Naidu MUR (2004). Randomised, double-blind, parallel, placebo-controlled study of oral glucosamine, methylsulfonylmethane and their combination in osteoarthritis. Clinical Drug Investigation. link
- 5Debbi EM, Agar G, Fichman G, Ziv YB, Kardosh R, Halperin N, Elbaz A, Beer Y, Debi R (2011). Efficacy of methylsulfonylmethane supplementation on osteoarthritis of the knee: a randomized controlled study. BMC Complementary and Alternative Medicine. link
- 6Berardesca E, Cameli N, Cavallotti C, Levy JL, Pierard GE, de Paoli Ambrosi G (2008). Combined effects of silymarin and methylsulfonylmethane in the management of rosacea: clinical and instrumental evaluation. Journal of Cosmetic Dermatology. link
- 7Brien S, Prescott P, Bashir N, Lewith H, Lewith G (2008). Systematic review of the nutritional supplements dimethyl sulfoxide (DMSO) and methylsulfonylmethane (MSM) in the treatment of osteoarthritis. Osteoarthritis and Cartilage. link
- 8Bannuru RR, Osani MC, Vaysbrot EE, Arden NK, Bennell K, Bierma-Zeinstra SMA, et al. (2019). OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthritis and Cartilage. link
MSM (Methylsulfonylmethane)
Roughly $15–30/year at 3 g/day in bulk audited-grade powder; capsules slightly more. Trivial relative to almost every other catalogue intervention.
A daily scoop in water or two capsules — a few seconds. The only friction is remembering to take it for the 8–12 weeks needed before judging joint effect.
Real mechanism — sulfur is structurally required for keratin disulfide bonds and collagen cross-linking (Butawan et al. 2017) — but supplementation effect over months in well-nourished adults is small and only documented in combination products and subjective endpoints. Score 2: real-but-small long-term contribution.
Four small placebo-controlled RCTs in knee OA (Kim et al. 2006; Usha and Naidu 2004; Debbi et al. 2011; Lubis et al. 2017) converge on roughly 25–30% VAS pain and WOMAC function reduction at 8–12 weeks. Modest but real symptomatic improvement for the right patient. The systematic review (Brien et al. 2008) calls the signal positive but not definitive.
Five small RCTs in knee OA (n=22–118, ≤12 weeks) consistent in direction; one systematic review (Brien et al. 2008) calls the signal positive but not definitive. No major guideline (OARSI 2019, ACR, AAOS) endorses MSM (Bannuru et al. 2019). Skin/hair/nail RCTs are smaller, combination-product, subjective-endpoint. Score 2 fits: sparse-to-emerging literature, mechanism plausible, no Cochrane-level synthesis.
Direct topical-tier skin effects are not credibly established. The Berardesca rosacea trial used silymarin + MSM so monotherapy effect is unidentifiable (Berardesca et al. 2008). No short-term visible facial transformation evidence; the 1 reflects a plausible-but-thin substrate role.